We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
A PracticeUpdate collaboration from Elsevier and the American Dental Association
Through the PracticeUpdate Clinical Dentistry Channel, Elsevier and the ADA have teamed up to bring you expert-curated updates from journals, news and educational resources, available 24/7, to keep you current with clinical advances.
Inferior alveolar nerve block success of 2% mepivacaine versus 4% articaine in patients with symptomatic irreversible pulpitis in mandibular molars: A randomized double-blind single-centre clinical trial
Int Endod J 2022 Aug 10;[EPub Ahead of Print], MFOM Habib, S Tarek, SME Teama, K Ezzat, RM El Boghdadi, A Marzouk, MY Fouda, SI Gawdat, MM Bedier, SAW Amin